Added to YB: 2020-12-24
Pitch date: 2020-12-24
PRTK:US [bullish]
Paratek Pharmaceuticals, Inc.
-66.72%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use.
Market Cap
$127.8M
Pitch Price
$6.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
-7.95
P/E
-2.00
EV/Sales
1.95
Sector
Pharmaceuticals
Category
N/A
Show full summary:
PARATEK PHARMACEUTICALS INC COM PRTK:US
A summary for this pitch has not been created yet.
Read full article (0 min)